Health Matters
  • Home
  • About
  • News
    • Top Stories
    • Recent News
    • Archive
  • Subscription Plans
  • Account
    • Profile
    • Corporate Account
    • Orders
    • Billing
    • Cancel
  • Levels
  • Contact
  • Login
Select Page

HIV Prevention in SA Needs Local Lenacapavir Manufacturing

by Stavros Nicolaou | Sunday Times | 14 December 2025

HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Spar’s Pharmacy Expansion Targets Health-Conscious Shoppers

by Thabiso Mochiko| Business Times | 14 December 2025

Spar Wellness Pharmacy Expansion taps into growing consumer demand for health and wellness, aiming to challenge Clicks and Dis-Chem.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

SA’s Healthcare Austerity Crisis Threatens Specialist Training

by Tara Roos | Business Day | 15 December 2025

SA's healthcare austerity crisis erodes specialist training and public health capacity, risking rights to care and driving emigration.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

2025 Health in Review: Challenges and Triumphs

by Marcus Low | Spotlight | 8 December 2025

Dive into the 2025 Health in Review, reflecting on South Africa's healthcare struggles and clinical successes in HIV and TB treatment.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Treasury Threatens Health Departments with Takeover

by Hajra Omarjee | Business Day | 8 December 2025

National Treasury threatens health departments in Gauteng, KZN, the Free State, and the Northern Cape with administrative management.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

1.4% SEP Increase Impacts Pharmaceutical Investment

by Linda Ensor | Business Day | 7 December 2025

Understanding the 1.4% SEP increase: why the pharmaceutical sector is urging a reconsideration of the price cap.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
« Older Entries
Next Entries »

Recent Posts

  • NHI Implementation: Understanding the Reform Facts
  • Gauteng Cardiac Surgery Outcomes and Controversies
  • Mediclinic Restructuring: Remgro Takes Full Control In SA
  • Grey’s Hospital HVAC Project Stalls as Vital Deadlines Pass
  • Charlotte Maxeke Cardiac Crisis: Alleged Failures at Major Hospital

Recent Comments

No comments to show.